Robert J. Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert J. Abraham has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A. Jehaan Illyas
1 shared publication- Aisling Coughlan
Inamori School of Engineering, Alfred University, Alfred, NY 14802, USA
1 shared publication Brock Vair
1 shared publication- Daniel Boyd
Department of Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, 5981 University Avenue, Halifax B3H 4R2, NS, Canada
1 shared publication - Jan K. Rainey
Department of Biochemistry & Molecular Biology Dalhousie University Halifax Nova Scotia B3H 4R2 Canada
1 shared publication - Marie-Laurence Tremblay
Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, NS B3H 4R2, Canada
1 shared publication
Latest Publications
- Open Access
- 10 July 2013
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 4 (3) , 89-113
Preliminary Investigation of the Dissolution Behavior, Cytocompatibility, Effects of Fibrinogen Conformation and Platelet Adhesion for Radiopaque Embolic Particles
Experimental embolic particles based on a novel zinc-silicate glass system have been biologically evaluated for potential consideration in transcatheter arterial embolization procedures. In addition to controlling the cytotoxicity and haemocompatibility for such embolic particles, its glass structure may mediate specific responses via dissolution in the physiological environment. In a 120 h in-vitro dissolution study, ion release levels for silicon (Si4+), sodium (Na+), calcium (Ca2+), zinc (Zn2+), titanium (Ti4+), lanthanum (La3+), strontium (Sr2+), and magnesium (Mg2+), were found to range from 0.04 to 5.41 ppm, 0.27–2.28 ppm, 2.32–8.47 ppm, 0.16–0.20 ppm, 0.12–2.15 ppm, 0.16–0.49 ppm and 0.01–0.12 ppm, respectively for the series of glass compositions evaluated. Initial release of Zn2+ (1.93–10.40 ppm) was only evident after 120 h. All compositions showed levels of cell viabilities ranging from 61.31 ± 4.33% to 153.7 ± 1.25% at 25%–100% serial extract dilutions. The conformational state of fibrinogen, known to induce thrombi, indicated that no changes were induced with respect of the materials dissolution by-products. Furthermore, the best-in-class experimental composition showed equivalency to contour PVA in terms of inducing platelet adhesion. The data generated here provides requisite evidence to continue to in-vivo pre-clinical evaluation using the best-in-class experimental composition evaluated.
- 10 July 2013
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 4 (3) , 89-113
Open AccessPreliminary Investigation of the Dissolution Behavior, Cytocompatibility, Effects of Fibrinogen Conformation and Platelet Adhesion for Radiopaque Embolic Particles
Experimental embolic particles based on a novel zinc-silicate glass system have been biologically evaluated for potential consideration in transcatheter arterial embolization procedures. In addition to controlling the cytotoxicity and haemocompatibility for such embolic particles, its glass structure may mediate specific responses via dissolution in the physiological environment. In a 120 h in-vitro dissolution study, ion release levels for silicon (Si4+), sodium (Na+), calcium (Ca2+), zinc (Zn2+), titanium (Ti4+), lanthanum (La3+), strontium (Sr2+), and magnesium (Mg2+), were found to range from 0.04 to 5.41 ppm, 0.27–2.28 ppm, 2.32–8.47 ppm, 0.16–0.20 ppm, 0.12–2.15 ppm, 0.16–0.49 ppm and 0.01–0.12 ppm, respectively for the series of glass compositions evaluated. Initial release of Zn2+ (1.93–10.40 ppm) was only evident after 120 h. All compositions showed levels of cell viabilities ranging from 61.31 ± 4.33% to 153.7 ± 1.25% at 25%–100% serial extract dilutions. The conformational state of fibrinogen, known to induce thrombi, indicated that no changes were induced with respect of the materials dissolution by-products. Furthermore, the best-in-class experimental composition showed equivalency to contour PVA in terms of inducing platelet adhesion. The data generated here provides requisite evidence to continue to in-vivo pre-clinical evaluation using the best-in-class experimental composition evaluated.
- 1 January 2012
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 23 (1) , 131-135
Endovascular Exclusion of a Splenic Artery Aneurysm Using a Pipeline Embolization Device
- 1 January 2012
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 23 (1) , 131-135
Endovascular Exclusion of a Splenic Artery Aneurysm Using a Pipeline Embolization Device